Consolidated Statements of Cash Flow (Unaudited) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
OPERATING ACTIVITIES
Net income	$ 206,916	$ 310,833	$ 232,277
Adjustments for non-cash items:
Depreciation	92,344	87,722	81,869
Amortization	20,760	16,351	11,602
Stock-based compensation expense	21,874	21,500	18,852
Restructuring charges			2,914
Deferred income tax provision (benefit)	232	28,602	(7,881)
Other	2,577	(12,702)	(9,872)
Changes in certain assets and liabilities:
Accounts receivable	33,801	(10,891)	(89,153)
Inventories	5,879	(63,833)	(124,082)
Accounts payable and accrued liabilities	(90,449)	(57,003)	100,325
Accrued income taxes	949	(14,157)	22,158
Other	(10,733)	(16,842)	(8,212)
Net cash flow provided by operating activities	284,150	289,580	230,797
INVESTING ACTIVITIES
Capital Expenditures	(82,835)	(103,036)	(83,442)
Disposals of property, plant and equipment	3,016	6,886	9,755
Business acquisition, net of cash acquired (Note 5)	(500)	(382,562)	0
Purchase of technology license	0	(10,000)	0
Proceeds from sale of investments in affiliated companies	0	0	1,723
Other	(379)	1,447	139
Net cash flow used for investing activities	(80,698)	(487,265)	(71,825)
FINANCING ACTIVITIES
Net (decrease) increase in notes payable	(833)	38,198	(15,992)
Net (decrease) increase in short-term revolving and other lines of credit	(23,600)	27,200	0
Term debt borrowings	944,152	1,509,767	450,109
Term debt repayments	(736,562)	(1,324,426)	(451,748)
Purchase of capital stock	(121,408)	(66,876)	(57,909)
Sale of subsidary stock	26,665	0	0
Settlement of interest rate swap agreement (Note 7)	0	(22,406)	0
Dividend reinvestment and the effect of employee benefit and stock plans	17,356	24,635	18,328
Cash dividends paid to shareowners	(51,011)	(43,631)	(39,801)
Other	(2,612)	(11,162)	988
Net cash flow provided by (used for) financing activities	52,147	131,299	(96,025)
Effect of exchange rate changes on cash and cash equivalents	5,251	(21,713)	23,489
CASH AND CASH EQUIVALENTS
Net increase (decrease) in cash and cash equivalents	260,850	(88,099)	86,436
Cash and cash equivalents, beginning of period	116,466	204,565	118,129
Cash and cash equivalents, end of period	$ 377,316	$ 116,466	$ 204,565